NASDAQ:AVTX Avalo Therapeutics (AVTX) Insider Trading & Ownership $4.15 +0.26 (+6.68%) (As of 05:11 PM ET) Add Compare Share Share Today's Range$3.74▼$4.2650-Day Range$1.75▼$3.8952-Week Range$1.41▼$7.41Volume41,972 shsAverage Volume48,460 shsMarket Capitalization$54.78 millionP/E RatioN/ADividend YieldN/APrice Target$15.50 Insider TradesProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Avalo Therapeutics (NASDAQ:AVTX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage45.40%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$318,884.59Number OfInsiders Selling(Last 12 Months)0 AVTX Insider Buying and Selling by Quarter Get AVTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Avalo Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Avalo Therapeutics Insider Trades History Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails5/30/2023Caissa Capital Management Ltd.Major ShareholderBuy671$2.87$1,925.771,385,371 5/25/2023Caissa Capital Management Ltd.Major ShareholderBuy2,000$2.77$5,540.001,384,700 5/22/2023Caissa Capital Management Ltd.Major ShareholderBuy7,000$3.34$23,380.001,373,700 5/18/2023Caissa Capital Management Ltd.Major ShareholderBuy13,121$3.29$43,168.091,360,200 5/15/2023Caissa Capital Management Ltd.Major ShareholderBuy1,715$2.55$4,373.251,346,700 5/12/2023Caissa Capital Management Ltd.Major ShareholderBuy2,285$2.45$5,598.251,344,985 5/8/2023Caissa Capital Management Ltd.Major ShareholderBuy5,000$2.62$13,100.001,342,700 5/4/2023Caissa Capital Management Ltd.Major ShareholderBuy15,000$2.79$41,850.001,332,700 4/26/2023Caissa Capital Management Ltd.Major ShareholderBuy425$2.97$1,262.251,316,196 4/24/2023Caissa Capital Management Ltd.Major ShareholderBuy12,500$3.06$38,250.001,310,200 4/20/2023Caissa Capital Management Ltd.Major ShareholderBuy5,000$3.08$15,400.001,297,700 4/17/2023Caissa Capital Management Ltd.Major ShareholderBuy15,000$2.96$44,400.001,282,700 4/10/2023Caissa Capital Management Ltd.Major ShareholderBuy31,329$2.28$71,430.121,242,700 12/9/2022Garry Arthur NeilCEOBuy2,083$4.42$9,206.869,220 (Data available from 1/1/2013 forward) AVTX Insider Trading Activity - Frequently Asked Questions Who is on Avalo Therapeutics's Insider Roster? The list of insiders at Avalo Therapeutics includes Armistice Capital, Llc, Caissa Capital Management Ltd., Christopher Ryan Sullivan, Garry Arthur Neil, H Jeffrey Wilkins, and Schond L Greenway. Learn more on insiders at AVTX. What percentage of Avalo Therapeutics stock is owned by insiders? 45.40% of Avalo Therapeutics stock is owned by insiders. Learn more on AVTX's insider holdings. Which Avalo Therapeutics insiders have been buying company stock? The following insiders have purchased AVTX shares in the last 24 months: Armistice Capital, Llc ($1,558,598.03), Caissa Capital Management Ltd. ($309,677.73), Christopher Ryan Sullivan ($1,499.35), Garry Arthur Neil ($9,206.86), H Jeffrey Wilkins ($10,002.47), and Schond L Greenway ($3,502.67). How much insider buying is happening at Avalo Therapeutics? Insiders have purchased a total of 1,946,283 AVTX shares in the last 24 months for a total of $1,892,487.11 bought. More Insider Trading Tools from MarketBeat Related Companies: CRBP Insider Ownership MGTA Insider Ownership RMTI Insider Ownership VINC Insider Ownership SYBX Insider Ownership ELDN Insider Ownership RAIN Insider Ownership HEPA Insider Ownership STSA Insider Ownership NLTX Insider Ownership Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Time To Buy Regional Banks? Insider Buying Says Yes2 Cheap Stocks And 1 Cheap Sector The Insiders Are BuyingTyson Insiders Buy Shares At Multi-Year Low3 High-Yield Banks Insiders Are Buying Insiders Drive Volatility For Keurig Dr Pepper This page (NASDAQ:AVTX) was last updated on 6/8/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avalo Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.